The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Pfizer
Approval Status: Approved January 1996
Treatment for: itching and redness of the eye
General Information
OcuHist has been approved as an over-the-counter antihistamine eye drop. Akorn, previously marketed this formulation as the prescription drug AK-Con-A.
With its active antihistamine ingredient pheniramine maleate (0.3%), and decongestant ingredient naphazoline hydrochloride (0.025%), OcuHist temporarily relieves itching and redness of the eye due to pollen, ragweed, grass, animal hair, and dander.
Additional Information
An estimated 50 million Americans are afflicted by pollen, ragweed, and other irritants.
